University of Michigan Rogel Cancer Center researchers received a $2 million grant from NCI to prepare the next generation of scientists focused on cancer care delivery.
Memorial Sloan Kettering and Hackensack Meridian Health have formed an Immunology Research Collaboration as part of their partnership. Through this joint initiative, researchers can apply for funding to support immunotherapy research.
Ashion Analytics, a clinical laboratory of the Translational Genomics Research Institute, an affiliate of City of Hope, is now part of NCI's MATCH program, which provides patients who have rare or difficult-to-treat cancers with access to unique clinical trials nationwide that might give them the best therapeutic treatments and outcomes.
Richard L Schilsky, chief medical officer of the American Society of Clinical Oncology, plans to retire Feb.28, 2021.
ASCO's CancerLinQ has launched a platform for CancerLinQ Discovery, its de-identified real-world cancer data product.
David Rivadeneira was named director of the Northwell Health Cancer Institute at Huntington. For the past seven years, Rivadeneira has led surgical services and colorectal surgery at Huntington Hospital.
MD Anderson Cancer Center and Rakuten Medical Inc. formed a collaboration to develop cancer therapies based on Rakuten Medical's Illuminox technology platform.
The Northwell Health Cancer Institute has recruited four experts to its cancer program:
Medical sociologist Pamela Hull was named associate director of population science and community impact at the University of Kentucky Markey Cancer Center
The University of Chicago Medicine received $10 million to develop personalized therapies for hard-to-treat cancers.
